Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Zedan

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Journal of Pediatric Ophthalmology and Strabismus|March 11, 2022
Botulinum Toxin Injection in Horizontal Rectus Muscles Without Electromyography Using an Open Sky Versus a Closed Sky TechniqueRehab R Kassem, Ranya A A Badr, Bandar K A Al Zarea, et al.
Translational Oncology|May 20, 2019
Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated CancerTorben Frøstrup Hansen, Line Nederby, Ahmed H Zedan, et al.
Cancers|May 13, 2026
The Prognostic Value of Proclarix in Prostate Cancer Patients Under Active Surveillance: Predicting Transition to Active Treatment and Disease Progression in a Danish CohortAlcibiade Athanasiou, Torben F Hansen, Jonna S Madsen, et al.
BMC Cancer|May 9, 2026
Proclarix' performance in ruling out patients with no or indolent prostate cancer: evaluation in a Danish populationRalph Schiess, Alcibiade Athanasiou, Madlen M E Kasten, et al.
Plos One|January 29, 2026
Methylation-specific, universal, and highly sensitive identification of ctDNA in prostate cancer by multiplex droplet digital PCRSøren Kahns, Ahmed H Zedan, Mads M Aagaard, et al.
European Urology Oncology|May 3, 2026
Pembrolizumab Plus Lenvatinib in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort EMarinela Augustin, Brigitte Laguerre, Capucine Baldini, et al.
European Urology Focus|August 12, 2025
Vibostolimab Coformulated with Pembrolizumab in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: KEYNOTE-365 Cohort GPeter C Fong, Mariusz Kwiatkowski, Alessandra Mosca, et al.
Applied Clinical Informatics|September 11, 2024
Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer CentersCarlos Berenguer Albiñana, Matteo Pallocca, Hayley Fenton, et al.
Psychological Medicine|November 17, 2025
Cross-national risk factors for childbirth-related PTSD: Findings from the INTERSECT studyJonathan E Handelzalts, Susan Ayers, Rebecca Webb, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Pediatric Ophthalmology and Strabismus|March 11, 2022
Botulinum Toxin Injection in Horizontal Rectus Muscles Without Electromyography Using an Open Sky Versus a Closed Sky TechniqueRehab R Kassem, Ranya A A Badr, Bandar K A Al Zarea, et al.
Translational Oncology|May 20, 2019
Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated CancerTorben Frøstrup Hansen, Line Nederby, Ahmed H Zedan, et al.
Cancers|May 13, 2026
The Prognostic Value of Proclarix in Prostate Cancer Patients Under Active Surveillance: Predicting Transition to Active Treatment and Disease Progression in a Danish CohortAlcibiade Athanasiou, Torben F Hansen, Jonna S Madsen, et al.
BMC Cancer|May 9, 2026
Proclarix' performance in ruling out patients with no or indolent prostate cancer: evaluation in a Danish populationRalph Schiess, Alcibiade Athanasiou, Madlen M E Kasten, et al.
Plos One|January 29, 2026
Methylation-specific, universal, and highly sensitive identification of ctDNA in prostate cancer by multiplex droplet digital PCRSøren Kahns, Ahmed H Zedan, Mads M Aagaard, et al.
European Urology Oncology|May 3, 2026
Pembrolizumab Plus Lenvatinib in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort EMarinela Augustin, Brigitte Laguerre, Capucine Baldini, et al.
European Urology Focus|August 12, 2025
Vibostolimab Coformulated with Pembrolizumab in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: KEYNOTE-365 Cohort GPeter C Fong, Mariusz Kwiatkowski, Alessandra Mosca, et al.
Applied Clinical Informatics|September 11, 2024
Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer CentersCarlos Berenguer Albiñana, Matteo Pallocca, Hayley Fenton, et al.
Psychological Medicine|November 17, 2025
Cross-national risk factors for childbirth-related PTSD: Findings from the INTERSECT studyJonathan E Handelzalts, Susan Ayers, Rebecca Webb, et al.
Pageof 5